Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 10, Issue 4, Pages 673-678Publisher
ASHLEY PUBLICATIONS LTD
DOI: 10.1517/13543784.10.4.673
Keywords
migraine attack; neurogenic inflammation; plasma extravasation; substance P; trigeminovascular system
Categories
Ask authors/readers for more resources
Clinical observations, the vascular component of migraine pain, its pulsating or throbbing pain character, have focused attention on the trigeminal innervation of pain-sensitive intracranial structures, such as the dura mater and large vessels. These intracranial structures are innervated by the ophthalmic branch of the trigeminal nerve, which is marked by the presence of vasoactive peptides, such as substance P and caicitonin gene-related peptide. Substance P is a mediator of the sterile inflammation of the dura mater, which has been considered to be the source of migraine pain. Modem antimigraine drugs, such as 5-HT1B/D agonists (triptans), block this dural neurogenic inflammation dose-dependently in an animal model but their vasoconstrictor effects have led to a search for non-vasoconstrictor approaches. One such approach has been substance P (neurokinin-1) antagonists. These are highly effective in animal models of dural inflammation and have no significant vasoconstrictive effect. However, several NK1 antagonists failed to demonstrate any effect in acute migraine. Current clinical and experimental evidence therefore supports the view that NK1 receptor antagonists may have no significant antimigraine properties.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available